IBA Health (ASX:IBA) iSoft Wins A$7.6 Million LORENZO Deal At New Macquarie University Private Hospital

Sydney, Australia, Oct 2, 2008 - (ABN Newswire) - iSOFT, an IBA Health Group Limited (ASX:IBA)(PINK:IBATF) today announced that the Macquarie University Private Hospital is set to become its first customer in the southern hemisphere for LORENZO Acute Care under a deal worth up to $7.6 million for a range of advanced healthcare IT applications at the new state-of-the-art hospital opening in the latter half of 2009.

Macquarie University Private Hospital will install iSOFT's innovative suite of clinical, administrative and financial applications delivering healthcare information to clinicians based in the hospital and in multi disciplinary clinic environments. The contract includes support and maintenance for six years with an option to extend for another three years. The hospital is taking LORENZO Acute Care for advanced clinical functionality to provide a full electronic medical record. The fully integrated solution for all administrative, clinical and management fun c tions will also link to new systems for radiology and pathology.

The LORENZO Acute Care platform is based on a Service-Oriented Architecture (SOA) which is a relatively recent approach to designing software solutions that are inherently standards based whilst delivering the interoperability necessary to connect people and processes across the hospital and multi disciplinary care settings. For hospital and clinic patients continuity of care will be assured at all points of need, whether in the hospital or clinic settings, or in ordinary living environments.

SOA based solutions are already widely used in many industry and commercial settings where the benefits of interoperability and support for process re-engineering have been proven. Now LORENZO represents the first substantial opportunity for the use of SOA in the healthcare market place.

Macquarie University Private Hospital will also be the first hospital in Australia to implement iSOFT Financials, an integrated suite of web-enabled financial and purchasing solutions.

The Macquarie University Private Hospital at North Ryde, Sydney is an $140 million joint venture development between Macquarie University and Dalcross Private Hospital and will provide 180 beds initially, increasing to 230 within two years, an advanced postgraduate medical school and specialists rooms. Sited on the university research park, the hospital will not only provide the highest quality of care, but also cutting-edge post graduate medical training and research.

iS OFT's solutions are fundamental in the drive to create one of the world's foremost technology-led hospitals. Information technology will be the key enabler across the hospital and university campus designed to set new standards in care, education and research.

Carl Adams, CEO of Dalcross Private Hospital, said: "The investment in iSOFT's solutions allows Dalcross to manage the new Macquarie facility with a confidence that the essential administrative and clinical requirements can be achieved immediately while simultaneously ensuring a pathway to the next generation of health information systems. As an early adopter of LORENZO Acute Care, we aim to play an active role in the development program and, with other users, help shape the future of healthcare IT systems."

Gary Cohen, IBA's Executive Chairman and CEO, said: "This contract marks a key milestone for the company giving us reference-ability and a foundation to drive sales of LORENZO Acute Care in th e region. With LORENZO, everyone has the opportunity to play an active role in the delivery of care. It breaks down barriers to critical clinical information helping healthcare professionals to make faster, informed decisions. There is a revolution in healthcare in which LORENZO will have a central role."

About Macquarie University Hospital

The new hospital will comprise 230 beds, twelve operating theatres, endoscopy, two cardiac and vascular angiography suites, extensive radiology and pathology facilities, radiotherapy and radiosurgery, and specialist consulting suites on campus. It will specialise in neurosurgery, ear nose and throat, cardiology, vascular surgery, ophthalmology, orthopaedics, general surgery, neurology, gastroenterology, and oncology services.

Dalcross has established an enviable reputation as one of Australia's foremost niche, independent private hospitals. Its referral base is international, especially for cerebrovascular a nd spinal surgery. The Macquarie University hospital will include an expanded surgical hospital to be relocated from Killara and a five-storey research, development and specialist clinic facility.

About: IBA HEALTH LIMITED

IBA Health Group Limited (ASX: IBA) is the largest specialist information technology company listed on the Australian Securities Exchange.

IBA builds software applications for healthcare. We work with healthcare professionals to design and build solutions that answer all of the difficult questions posed by today's care delivery challenges. Our solutions act as a catalyst for change, supporting the free exchange of critical information across diverse care settings and participant organisations. We are the leader in the provision of advanced application solutions in modern healthcare economies around the world.

Today, over 13,000 provider organisations in 35 countries across five continents use IBA's solutions to ma n age patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of our market and anticipation of evolving requirements. Our business is driven by the collective talent, experience and commitment of over 3,500 healthcare IT experts around the globe.

A global network of IBA subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result we offer our customers comprehensive knowledge of local market requirements, in terms of culture, language, working practice, healthcare regulation and organisational structure.

For more information on IBA Health, please visit the Company's website at www.ibahealth.com

MORE ON THIS TOPIC